Baxter Healthcare Corporation: Daptomycin, In 0.9% Sodium Chloride Injection, 1,000 Mg Per
Recall Summary Baxter Healthcare is recalling Daptomycin 1,000 mg in 0.9% Sodium Chloride Injection (NDC 0338-0718-12) distributed nationwide in the US, Puerto Rico, and Chile due to manufacturing process deviations that don't meet current good manufacturing practice standards. This is a Class II recall, meaning the product could cause adverse health effects. The recall affects this specific injectable antibiotic product used in hospitals and healthcare settings.
- Recalling firm
- Baxter Healthcare Corporation
- Product
- Daptomycin, in 0.9% Sodium Chloride Injection, 1,000 mg per 100 mL (10 mg/mL), 1,000 mg total, in 1000 mL Single Dose Container, Rx only, Sterile Nonpyrogenic, Baxter Healthcare Corporation, Deerfield, IL 60015 USA, NDC 0338-0718-12.
- Reason
- CGMP Deviations
- Classification
- Class II
- Category
- drug recall
- Country
- United States
- Agency
- U.S. Food and Drug Administration
- Recall date
- 2026-08-06
- Status
- Ongoing
- Areas affected
- AL, AK, AZ, AR, CA, CO, CT, DE, FL, GA, HI, ID, ...
- Distribution
- US Nationwide; Puerto Rico; and Chile.
Official recall notice from U.S. Food and Drug Administration
Recall details on Nibble Recalls: https://trynibble.app/recalls/f33d88c1-1c25-47b2-b7a7-6f0a8fc86df8